Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Allergic Reactions02:06

Allergic Reactions

28.5K
Overview
28.5K
Allergic Drug Reactions01:27

Allergic Drug Reactions

972
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
972
Hypersensitivities01:30

Hypersensitivities

1.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.0K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Efficacy and Safety of Dupilumab in Eosinophilic Esophagitis: A Systematic Review and Meta-Analysis.

International archives of allergy and immunology·2026
Same authorSame journal

Anaphylaxis Clinical Care Pathway: Incorporating Intranasal Epinephrine (Adrenaline).

The journal of allergy and clinical immunology. In practice·2026
Same author

The Chronic Angioedema Registry: what the first 2 years since the implementation of the global registry have taught us.

Frontiers in allergy·2026
Same author

Immune-stromal dysregulation and senescence in chronic spontaneous urticaria.

The journal of allergy and clinical immunology. Global·2026
Same author

Autoinflammatory syndromes in chronic urticaria are rare but clinically distinct: A retrospective cohort study.

JAAD international·2026
Same author

Effectiveness of a Provincial Law to Improve Epinephrine Use for Anaphylaxis in Schools in Alberta, Canada: A Pre-Post Study.

International archives of allergy and immunology·2026

関連する実験動画

Updated: Sep 9, 2025

Measuring Local Anaphylaxis in Mice
07:49

Measuring Local Anaphylaxis in Mice

Published on: October 14, 2014

19.5K

イディオパシー アナフィラキシー グランドラウンド

Moshe Ben-Shoshan1, Cem Akin2, Victoria E Cook3

  • 1Division of Allergy, Immunology&Dermatology, Department of Pediatrics, Montreal Children's Hospital, Montreal QC, Canada.

The journal of allergy and clinical immunology. In practice
|August 29, 2025
PubMed
まとめ

Idiopathic anaphylaxis (IA) は,明確なトリガーのない再発性過敏反応の難しい診断です. この事件は17歳の

キーワード:
アナフィラキシーイディオパシーアナフィラキシーマスト細胞活性化症候群マストセルトリプトーゼ

さらに関連する動画

Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation
04:34

Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation

Published on: September 14, 2018

25.8K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.5K

関連する実験動画

Last Updated: Sep 9, 2025

Measuring Local Anaphylaxis in Mice
07:49

Measuring Local Anaphylaxis in Mice

Published on: October 14, 2014

19.5K
Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation
04:34

Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation

Published on: September 14, 2018

25.8K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.5K

科学分野:

  • 免疫学
  • アレルギー
  • 臨床医学

背景:

  • イディオパシーアナフィラキシー (IA) は,特定可能なトリガーを欠いた,再発性,生命を脅かす過敏反応であり,重要な診断および治療上の課題をもたらします.
  • IAは,IgE媒介性アレルギー,コファクター依存性アナフィラキシー,マスト細胞疾患,全身性ミミックを含む包括的な差異診断を必要とします.
  • 現在の治療はしばしば予防用抗ヒスタミン剤とコルチコステロイドを用い,耐火性の症例に対する抗IgE治療を支持する新たな証拠が出ています.

研究 の 目的:

  • 17歳の少女の アナフィラキシーについてです
  • イディオパシーアナフィラキシーの診断と管理戦略をレビューする.
  • IAの診断において他の疾患を除外することの重要性を強調する.

主な方法:

  • 17歳の女性で アナフィラキスが再発した
  • 診断の評価には,血清トリプターゼ濃度,皮膚刺検査,アルファガルIgE検査,KIT変異分析が含まれていた.
  • 治療はセチリジンによる予防療法で,症状は解消し,さらなる反応は発生しなかった.

主要な成果:

  • 患者は発症原因が特定できない 繰り返し発疹,,呼吸器症状を経験しました.
  • 血清トリプターゼ濃度の上昇が観察され,基準値は正常であり,アレルギー検査は陰性であった.
  • 予防的なセチリジンは,さらなるアナフィラキシー反応を効果的に予防しました.

結論:

  • イディオパシーアナフィラキシは排除の診断であり,他の原因を排除するために徹底的な調査が必要である.
  • このケースは,抗ヒスタミン予防の潜在的有効性をIAの管理に示しています.
  • 診断経路の標準化とIAの長期的な治療戦略の最適化にはさらなる研究が不可欠です.